tirzepatide and nash Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review Tirzepatide achieves high NASH resolution

McGibbon, A., Adams, L., Ingersoll, K., Kader, T

Postmenopausal women with central weight and inflammaging: Women after menopause who see central fat gain, rising A1c, joint aches, hotcold energy swings, and elevated inflammatory markers and may already be on, or appropriate for, wellmanaged HRT

In the context of GLP-1 therapy, glycine addresses the single biggest concern that clinicians and patients share: losing muscle along with fat

BPC 15mg $66.00 BPC-157 (15mg) is a research-grade synthetic pentadecapeptide for laboratory use, available in a larger quantity format for researchers requiring higher volume for multi-condition experimental designs

Besides its glucose-lowering and anti-obesity effects, tirzepatide has been reported to have potential cardiovascular benefits